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Abstract
Expression of the murine leukaemia virus (MLV) major Gag antigen p65Gag using the baculovirus expression system leads to efficient
assembly and release of virus-like particles (VLP) representative of immature MLV. Expression of p180Gag-Pol, facilitated normally in
mammalian cells by readthrough of the p65Gag termination codon, also occurs efficiently in insect cells to provide a source of the MLV
protease and a pattern of p65Gag processing similar to that observed in mammalian cells. VLP release from p180Gag-Pol-expressing cells
however remains essentially immature with disproportionate levels of the uncleaved p65Gag precursor when compared to the intracellular
Gag profile. Changing the p65Gag termination codon altered the level of p65Gag and p180Gag-Pol within expressing cells but did not alter the
pattern of released VLP, which remained immature. Coexpression of p65Gag with a fixed readthrough p180Gag-Pol also led to only immature
VLP release despite high intracellular protease levels. Our data suggest a mechanism that preferentially selects uncleaved p65Gag for the
assembly of MLV in this heterologous expression system and implies that, in addition to their relative levels, active sorting of the correct
p65Gag and p180Gag-Pol ratios may occur in producer cells.
© 2003 Elsevier Inc. All rights reserved.
Introduction
Murine leukaemia virus (MLV) is one of the most widely
used vectors for gene delivery. Its productivity is limited
however with routine titres of 106–7 PFU/ml compared to
1012–13 PFU/ml for adenovirus-based systems (reviewed by
Miller, 1997). Higher titres of MLV have been obtained
when expression of the structural genes gag-pol and env
were placed under the control of the CMV promoter (So-
neoka et al., 1995), suggesting that high-level heterologous
expression of the individual components of the virus might
provide the basis for a system of high-titre retrovirus vector
production. Expression of the major retrovirus capsid gene,
gag, in a number of protein expression systems such as
bacteria (Joshi and Vogt, 2000; Luschnig et al., 1995;
Morikawa et al., 2001; Rumlova-Klikova et al., 2000), yeast
(Sakuragi et al., 2002), insect cells (Gheysen et al., 1989;
Johnson et al., 2001; Jones and Morikawa, 1998; Kakker et
al., 1999; Luo et al., 1990; Morikawa et al., 1991; Nermut
et al., 1994; Sommerfelt et al., 1993; Takahashi et al., 1999;
Yamshcikov et al., 1995), and mammalian cells (Haynes et
al., 1991; Jenkins et al., 1991; Karacostas et al., 1989;
Krausslich et al., 1993; Shioda and Shibuta, 1990) has led to
the synthesis of virus-like particles (VLPs) that mimic the
immature form of the authentic virus. Particularly wide-
spread use has been made of the expression of Gag in insect
cells using recombinant baculoviruses, with VLP assembly
being reported for HIV-1 and -2 (Gheysen et al., 1989; Luo
et al., 1990), SIV (Yamshcikov et al., 1995), BIV (Rasmus-
sen et al., 1990), FIV (Morikawa et al., 1991), BLV (Kakker
et al., 1999), HTLV-II (Takahashi et al., 1999), RSV (John-
son et al., 2001), and M-PMV (Sommerfelt et al., 1993). In
contrast coexpression of Gag with retroviral protease, either
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as part of the complete gag-pol gene or as Gag-Pro, fails to
generate VLPs (Gheysen et al., 1989; Hughes et al., 1993;
Johnson et al., 2001; Morikawa et al., 1991; Wagner et al.,
1992), a finding suggested to be the result of premature
activation of the retroviral protease in insect cells and con-
sequential degradation of the Gag precursor prior to VLP
assembly (Gheysen et al., 1989; Hughes et al., 1993;
Morikawa et al., 1991; Wagner et al., 1992). Alteration of
protease activity by mutagenesis or through the use of
antiretroviral drugs alters the relative ratio of Gag and
Gag-Pol in producer cells but fails to rescue VLP assembly
unless the protease is essentially inactivated (Adamson et
al., 2003), arguing that the coincorporation of Gag and
Gag-Pol may be more active than previously thought. For
all the retroviruses for which insect cell expression of gag-
pol has been investigated, the viral protease is produced as
part of the Gag-Pol fusion protein by frameshifting at the
end of the gag gene. In MLV, however, p180Gag-Pol expres-
sion is achieved through an in-frame readthrough suppres-
sion of the p65Gag UAG termination codon by host cell
tRNAGln (Yoshinaka et al., 1985). Thus, in contrast to the
situation where relative Gag and Gag-Pol levels are set by
the rate of frameshifting, a relative level suitable for the
assembly of MLV VLP with a mature phenotype could
follow expression of the MLV structural genes in insect
cells. Such a system could provide a method for the large-
scale production of mature particles for structural study as
well as higher titres of gene delivery vectors. Here we
describe the expression of MLV p65Gag and p180Gag-Pol in
insect cells using recombinant baculoviruses. We show that,
in common with many retroviral precedents, MLV p65Gag
assembles into immature VLPs but that, unlike in previous
studies, incorporation of the Pol domain does not result in
the cessation of VLP assembly but in the retention of syn-
thesis of VLPs with an immature morphology. Purposeful
alteration of the p65Gag:p180Gag-Pol ratio through mutation
of the readthrough site failed to recover mature particle
assembly, whereas permanent readthrough resulted in com-
plete loss of VLP assembly. Our data suggest that, irrespec-
tive of the molecular mechanism by which the ratio is
achieved, additional factors may modulate the correct ratios
of p65Gag and p180Gag-Pol required for mature particle for-
mation.
Results
MLV p65Gag assembles into immature virus-like particles
in insect cells
The normal pathway for the assembly of mature infec-
tious MLV involves proteolytic maturation of the p65Gag
precursor by the MLV encoded protease (Crawford and
Goff, 1984; Katoh et al., 1985; Yoshinaka et al., 1985). The
protease cleaves p65Gag into four major proteins; the matrix
protein (p15Gag), the late domain (p12Gag), the capsid pro-
tein (p30Gag), and the nucleocapsid protein (p10Gag). Mat-
uration results in a structural rearrangement producing viri-
ons with a characteristic mature morphology (Yeager et al.,
1998; Yoshinka and Luftig, 1977). To assess if insect cell
expression of MLV p65Gag and p180Gag-Pol could mimic
this, the gag gene was excised from plasmid p6565 (Yap,
2000) and cloned into the baculovirus transfer vector
pBAC4x-1 (Cambridge Bioscience), placing gag under the
control of the baculovirus p10 promoter. A p180Gag-Pol
transfer vector was similarly constructed except that the
gag-pol gene was amplified by PCR from plasmid pgag-
polgpt (Markowitz et al., 1988) and placed under control of
the pBac4x-1 polyhedrin promoter. Recombinant baculovi-
ruses AcMLVGag and AcMLVGag-Pol were constructed by
standard procedures using BacPAK6 viral DNA (Clontech).
Following growth of virus stocks and high multiplicity
infection (m.o.i.  5), expression of p65Gag and p180Gag-Pol
products were assessed at 2 days postinfection (pi) using
12% SDS–PAGE and Western blotting using anti-p30Gag
antibody (Quality Biotech Inc.). Cells infected with
AcMLVGag showed abundant synthesis of uncleaved MLV
p65Gag when blotted with anti-p30Gag that comigrated with
p65Gag expressed in mammalian 293T cells (Fig. 1A, tracks
2 and 4). Some general proteolytic degradation of p65Gag
was apparent but no distinct p30Gag band was present in
Fig. 1. Western blot analysis of MLV p65Gag proteins expressed in Sf9 and
293T cells. Cell lysates and supernatants were harvested and adjusted to an
equivalent total protein concentration. Protein loading of cellular extracts
was 20 g/lane for mammalian cell samples and 2 g/lane for insect cell
samples. Supernatants were prepared by low-speed clarification followed
by pelleting (14K rpm, 30, 4°C) to eliminate secreted Gag monomers.
Western blotting was done with a goat anti-p30Gag serum to detect MLV
proteins and a monoclonal antibody to gp67, the major baculovirus gly-
coprotein, as marker for baculovirus infection. Primary antibodies were
incubated with appropriate conjugates and the blots were finally developed
using BM chemiluminescence (Roche). The samples analysed were as
follows: 1, nontransfected 293T cells (control); 2, 293T cells transfected
with pHIT60 (Soneoka et al., 1995) expressing p180Gag-Pol; 3, Sf9 cells
infected with BacPAK6 (control); 4, AcMLVGag; 5, AcMLVGag-Pol. In-
fected cell lysates (A and C) or supernatants (B) were collected 48 h
postinfection and resolved by 12% SDS–PAGE before Western blotting
using anti-p30Gag antibody (A and B) or anti-gp67 (C). The position of
uncleaved p65Gag, cleaved p30Gag, and baculovirus gp67 is indicated.
489C.S. Adamson et al. / Virology 314 (2003) 488–496
keeping with a construct lacking the Pol domain. By con-
trast, cells infected with AcMLVGag-Pol showed extensive
proteolytic processing of p65Gag with cleaved p30Gag being
the predominant Gag protein detected and only low levels of
the uncleaved p65Gag when compared to AcMLVGag-in-
fected cells (Fig. 1A, compare tracks 4 vs 5). The observed
proteolytic processing of p65Gag following expression of the
MLV p180Gag-Pol fusion protein indicated readthrough of
the MLV p65Gag stop codon by insect cell tRNAs. The
overall expression of p65Gag and p180Gag-Pol was estimated
to be10-fold higher than that in mammalian cells on a per
expressing cell basis, confirming the potential of heterolo-
gous expression for the production of high levels of viral
particles. When supernatants from infected cells were
probed with anti-p30Gag, AcMLVGag-infected cells showed
a strong band at p65Gag, reflecting the intracellular expres-
sion profile of Gag and suggesting efficient release of un-
cleaved p65Gag (Fig. 1B, tracks 4 and 5). Supernatants from
AcMLVGag-Pol-infected cells also showed predominantly
p65Gag, in contrast to the intracellular Gag profile, although
some p30Gag was also visible by Western blot (Fig. 1B,
track 5). A pattern of fully cleaved p30Gag, with no p65Gag
in the supernatant, was shown by MLV harvested from the
supernatant of transfected 293T cells (Fig. 1B, track 2).
Similar results were obtained when a p15Gag antibody was
used for blotting (data not shown). Thus, despite suppres-
sion of the gag termination codon in insect cells to provide
a mix of Gag and Gag-Pol products, predominantly un-
cleaved p65Gag entered the VLP assembly pathway.
To assess the nature of the MLV antigen released from
infected Sf9 cells, the sedimentation profiles of antigen on
sucrose velocity gradients, diagnostic of VLP assembly,
were analysed. Supernatants from AcMLVGag-infected cells
showed a major band at the position of p65Gag (Fig. 2A) that
peaked in the 45% sucrose fraction as reported for other
C-type retrovirus particles (Jowett et al., 1992). VLPs
present in the supernatant from AcMLVGag-Pol-infected
cells also peaked in the middle of the gradient and were
similarly associated with p65Gag, although some p30Gag
cobanded and were also present at lighter densities (Fig.
2B). MLV particles released from transfected 293T cells
banded at a similar position in the gradients but were asso-
ciated only with fully cleaved p30Gag antigen (Fig. 2C).
These data suggested that MLV virus-like particles are
efficiently budded from insect cells following high-level
expression of MLV p65Gag or p180Gag-Pol. The Gag profile
by blot however suggested that maturation of VLPs does not
occur, or occurs with very low efficiency, despite demon-
strably high MLV protease activity in the producer cells.
To confirm that MLV Gag-derived antigen released into
the supernatant of AcMLVGag-Pol-infected Sf9 cells was in
the form of nonmaturing VLPs, infected cells were fixed,
thin-sectioned, and examined by transmission electron mi-
croscopy (TEM). Typical fields showed profuse budding of
MLV VLPs with an immature morphology at the infected
cell surface (Fig. 3A). Occasionally, a field of VLPs showed
a single particle with a morphology that would be consistent
with a mature phenotype (Fig. 3B) but the overall level was
extremely low (0.1%), did not reflect the levels of p30Gag
observed in the banded VLP preparations used for adsorp-
tion to the grids, and failed to be confirmed by reverse
transcriptase assay or blot by anti-RT antibody, all of which
which showed barely detectable activity when compared
with mammalian cell-derived controls (data not shown).
Variable p65Gag and p180Gag-Pol expression levels fails to
rescue mature VLP
Failure to assemble maturation competent VLPs, despite
evidence for activation of the MLV protease in insect cells
expressing MLV p180Gag-Pol, could have been the result of
an inappropriate balance of p65Gag and p180Gag-Pol in the
expressing cells. To address this, the wild-type UAG codon
at the end of the gag gene was mutated to each alternate stop
codon, UAA and UGA. Previous studies showed that these
alternate termination codons allowed equivalent rates of
suppression to the original UAG termination codon, at least
in mammalian cells and cell lysates (Feng et al., 1989). In
addition, UAG was changed to CAG (encoding glutamine)
Fig. 2. Sucrose gradient analysis of VLPs assembled in Sf9 and 293T cells.
VLPs present in the supernatant were sedimented through a 20–60% step
sucrose gradient made up in PBS. Gradients were fractionated from the top
and VLPs produced from Sf9 cells infected with AcMLVGag (A) and
AcMLVGag-Pol (B) or from 293T cells transfected with pHIT60 (C) were
detected by 12% SDS–PAGE and Western blotting using goat anti-p30Gag
antibody followed by an anti-goat peroxidase conjugate and chemilumi-
nescence.
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to produce constitutive expression of the Gag-Pol fusion
protein. Following mutant construction and verification, re-
combinant baculoviruses AcMLVGag-Pol-UAA, AcMLVGag-
Pol-UGA, and AcMLVGag-Pol-CAG were generated and their
expression profile was assessed by SDS–PAGE and West-
ern blotting using the anti-p30Gag antibody as before. A
number of cleavage intermediates, but less fully cleaved
p30Gag protein, was observed in cell extracts prepared from
cells infected with AcMLVGag-Pol-UAA, suggesting that
UAA is more poorly suppressed than the parental sequence
by insect cell tRNAs. Similarly, change of UAG 3 UGA
resulted in intermediate p65Gag and p30Gag levels compared
to those associated with expression of parental p180Gag-Pol
(Fig 4, compare track 7 with track 5), while change of UAG
3 CAG resulted in the production of p180Gag-Pol fusion
protein independent of termination codon readthrough and
showed very little p65Gag but prominent partial cleavage
products and substantial levels of p30Gag consistent with
high-level protease production and essentially complete
p65Gag degradation (Fig 4A, track 8). To assess if altered
p65Gag levels in the expressing cells influenced the Gag
profile of the VLPs formed, supernatants from infected cells
were concentrated and analysed as before. Gag-derived pro-
teins released into the supernatant from AcMLVGag-Pol-
UAA-infected cells consisted of p65Gag with no p30Gag (Fig
4B, track 6). Supernatants from AcMLVGag-Pol-UGA-in-
fected cells similarly showed only p65Gag (Fig. 4B, track 7),
while cells infected with AcMLVGag-Pol-CAG failed to
Fig. 3. Electron microscopy of assembled MLV VLPs. Representative thin-section electron micrographs of MLV VLPs were assembled in Sf9 cells infected
with AcMLVGag-Pol. Samples were prepared as described by Jowett et al. (1992) and stained as described by Hockley et al. (1988) before being examined
using a Philips CM12 electron microscope operating at 80 KV. The majority of VLPs examined had a morphology typical of immature viruses (A), but very
occasionally a VLP with a morphology resembling that of a mature virion was observed (B, indicated). Rod-shaped baculoviruses are also present sectioned
at various angles in both panels. Bar is 100 nm.
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show any Gag-derived antigen in the supernatant (Fig. 4B,
track 8), as expected of a construction that does not express
any full-length p65Gag (Felsenstein and Goff, 1988). TEM
analysis of pelleted VLP material failed to show any parti-
cles with an apparent mature morphology as was the case
with VLP produced by AcMLVGag-Pol and no supernatant
had appreciable RT activity (data not shown). None of the
stop codon mutations altered the level of p30Gag in the
supernatant to the levels associated with the p30Gag present
in the supernatant of transfected mammalian cells express-
ing MLV p180Gag-Pol (Fig. 4B, track 2). Thus, although
modulation of the readthrough event through alteration of
the stop codon clearly changed the relative levels of p65Gag
and p30Gag in expressing cells, those profiles were not
mirrored in the VLP population.
Coexpression of p65Gag and p180Gag-Pol fails to rescue
mature VLP formation
Singular expression of the gag-pol gene in insect cells
resulted in expression of p65Gag and p180Gag-Pol at a relative
level dependent on the readthrough rate. To assess if the
failure to incorporate the correct levels of p65Gag and
p180Gag-Pol to allow both particle assembly and maturation
was related to expression of the required proteins from a
single transcriptional unit, cells were coinfected with
AcMLVGag and AcMLVGag-Pol-CAG to express uncleaved
p65Gag and p180Gag-Pol from different mRNA transcripts.
Coinfection by baculoviruses at high multiplicity is an ef-
ficient method for coexpression of two antigens in the same
cell (Belyaev et al., 1995). Following coinfection, superna-
tants were harvested and the VLPs present were analysed by
sedimentation through velocity gradients followed by SDS–
PAGE and Western blotting. MLV Gag antigen was present
in fractions of approximately 45% sucrose as before
(Fig. 5A) but, despite coexpression of the readthrough
p180Gag-Pol domain, the predominant band was at p65Gag
with a relatively low level of p30Gag when compared to the
cellular profile and no evidence of enhanced maturation
beyond that was seen in cells expressing AcMLVGag-Pol
(Fig. 5B). As with the alternate stop codon mutants, no
MLV particles with a mature morphology were apparent
following EM examination (data not shown). Coexpression
of p65Gag and p180Gag-Pol from different transcripts there-
Fig. 5. Sucrose gradient analysis of VLPs assembled after Sf9 cell
coinfection with AcMLVGag and AcMLVGag-PolCAG. VLPs present in
the supernatant of Sf9 cells infected with AcMLVGag or AcMLVGag 
AcMLVGag-PolCAG were sedimented through a 20–60% step sucrose
gradient and analysed as described for Fig. 2. (A) Gradient profile for
AcMLVGag-Pol only (as in fig. 2B); (B) gradient profile of coinfection of
AcMLVGag and AcMLVGag-PolCAG. VLP were detected by 12% SDS–
PAGE and Western blotting using anti-p30Gag antibody following gradient
fractionation from the top.
Fig. 4. Western blot analysis of p65Gag proteins expressed by p65Gag
termination codon mutants in Sf9 cells. Cell lysates and supernatants were
prepared as described for Fig. 1. The samples analysed were as follows: 1,
nontransfected 293T cells (control); 2, 293T cells transfected with pHIT60
expressing p180Gag-Pol; 3, Sf9 cells infected with BacPAK6; 4, AcMLVGag;
5, AcMLVGag-Pol; 6, AcMLVGag-PolUAA; 7, AcMLVGag-PolUGA; 8, Ac-
MLVGag-PolCAG. Infected cell lysates (A and C) or supernatants (B) were
collected 48 h postinfection and resolved by 12% SDS–PAGE and Western
blot using anti-p30Gag antibody (A and B) or anti-gp67 (C). The blot is a
composite and the positions of uncleaved p65Gag, cleaved p30Gag, and the
baculovirus expressed gp67 are indicated.
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fore makes no difference in the selection of uncleaved
p65Gag during particle assembly and the failure to form
particles with a mature morphology.
Discussion
The Gag precursor protein is the main structural unit of
retroviral assembly and its ability to assemble into VLPs in
heterologous expression systems has previously been dem-
onstrated for numerous retroviruses with the exception of
HTLV-1 (Bouamr et al., 2000) and RSV (Johnson et al.,
2001). Assembly of immature VLPs following expression
of MLV p65Gag was expected therefore, despite not being
formally demonstrated previously. The expression of MLV
p180Gag-Pol resulted in abundant levels of the cleaved
p30Gag and indicated that suppression of the p65Gag termi-
nation codon occurred efficiently in insect cells. In studies
on retroviruses whose relative Gag and Gag-Pol levels are
set by frameshifting, activation of the protease in heterolo-
gous expression systems leads to cessation of particle as-
sembly. Surprisingly however, in the case of MLV, expres-
sion of p180Gag-Pol resulted in the continued assembly of
VLPs, which contained high levels of uncleaved p65Gag and
exhibited an immature morphology by TEM. The failure to
form mature particles could be due to one of two factors:
firstly a level of p65Gag and p180Gag-Pol incompatible with a
VLP structure that is enabled for further p65Gag processing,
or alternately, the lack of a host specific factor or environ-
ment necessary for the correct packing of p65Gag and
p180Gag-Pol. The former possibility seems unlikely as we
observed efficient translational readthrough in insect cells
and showed that mutation of the gag stop codon signifi-
cantly altered intracellular Gag ratios yet did not concomi-
tantly alter the profile of budded VLPs. In addition, coex-
pression of similar levels of p65Gag with a p180Gag-Pol
fusion protein mutated to provide permanent readthrough,
effectively boosting the intracellular level of protease, did
not alter the form of budded VLP. Some cleaved p30Gag
antigen was found associated with VLPs following coincor-
poration of p180Gag-Pol into VLPs but the lack of overt VLP
maturation was consistent with that being nonspecifically
associated with VLPs in, for example, membrane fragments
released from lysed cells or by passive capture of p30Gag by
the budding VLP. Retrovirus protease expression in insect
cells has been variously observed to be uncontrolled, cyto-
toxic, and generally incompatible with VLP formation
(Gheysen et al., 1989; Johnson et al., 2001). This was not
the case for MLV where, in the case of coinfection of
AcMLVGag and AcMLVGag-Pol-CAG, high levels of pro-
tease were present but VLP synthesis was maintained and
no particle maturation occurred. An alternate explanation is
that particle assembly may involve an active sorting process
requiring more than the presence of a suitable p65Gag:
p180Gag-Pol ratio and that key factors, either required for ini-
tiating maturation directly or required for loading assem-
bling particles with the correct ratios of p65Gag and
p180Gag-Pol, are poorly represented in, or absent from, insect
cells. A similar conclusion was reached in a recent study
which examined the rescue of mature HIV-1 VLPs from
insect cells following modulation of protease activity (Ad-
amson et al., 2003).
The existence of cis-acting “late” assembly signals has
been known for retroviruses since 1991 (Gottlinger et al.,
1991) and recent data show them to interact with host cell
factors such as Nedd 4 and TSG101 (Demirov et al., 2002a;
Garrus et al., 2001; Kilonyogo et al., 2001; Martin-Serrano
et al., 2001; Myers and Allen, 2002; Puffer et al., 1998;
VerPlank et al., 2001), whose function appears, principally,
to direct virus particle trafficking and budding (reviewed by
Freed, 2002). Interestingly, however, mutations in the late
domain of HIV-1 Gag have been associated with defective
Gag processing (Demirov et al., 2002b; Gottlinger et al.,
1991; Huang et al., 1995) and the loading of assembling
viruses with the normal amounts of the pol-encoded en-
zymes (Demirov et al., 2002b; Dettenhofer and Yu, 1999;
Yu et al., 1998), providing a link between late domain
function and the ability of the particle to mature. Moreover,
the requirement for late factors can be bypassed if protease
is missing or inactive (Huang et al., 1995; Schubert et al.,
2000), although the reason for this remains unclear. Our
data show that MLV budding, which also uses a late domain
(Yuan et al., 2000), was efficient in heterologous cell types
irrespective of the presence of active protease but that on-
ward maturation did not occur. This might suggest that
factors involved in late virus assembly have an active role in
sorting Gag into the assembling virion in addition to allow-
ing the assembled virus to bud efficiently from the plasma
membrane. Our data on MLV assembly in insect cells, in
which Gag readthrough rather than frameshifting achieves
the relative balance of p65Gag and p180Gag-Pol, is consistent
with the lack of maturation obtained in systems that have
attempted heterologous expression of mature HIV (Adam-
son et al., 2003; Gheysen et al., 1989) and suggests a
common defect that is not related to the molecular mecha-
nism of Gag translational control. If the action of viral late
factors, or the microenvironment they enable, can be under-
stood in detail, there seems no reason retroviral vectors
could not be assembled in heterologous cells with concom-
itant improvements in titre and safety.
Materials and methods
Cell culture
Insect serum-free adapted Spodoptra frugiperda (Sf9)
cells were propagated at 28°C as described by O’Reilly et
al. (1992) except that Sf-900 II media (Gibco-BRL Life
Technologies) were used throughout. Mammalian 293T
cells (cell bank, Oxford University) were propagated at
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37°C, 5% CO2 in Dulbecco’s modified Eagle’s medium
(Sigma) supplemented with 10% v/v heat-inactivated foetal
calf serum (Gibco-BRL Life Technologies) and 1% v/v 200
mM L-glutamine (Gibco-BRL Life Technologies).
Construction of recombinant transfer vector
Recombinant transfer vectors expressing MLV p65Gag
and p180Gag-Pol were constructed. The gag gene was excised
from plasmid p6565 (Yap, 2000) using BamHI and EcoRI
restriction sites. Restriction sites BgIII and EcoRI were then
used to clone the gag gene into the transfer vector
pBAC4x-1 (Cambridge Bioscience), placing gag under the
control of a p10 promoter. The Gag-Pol transfer vector was
constructed by amplifying gag-pol by PCR from plasmid
pgag-polgpt (Markowitz et al., 1988). Gag-Pol was inserted
into the BamHI and NotI restriction sites of transfer vector
pBAc4x-1, placing the gene under the control of the poly-
hedrin promoter.
Mutations to alter the p180Gag-Pol frameshift site by chang-
ing the UAG termination codon to alternative termination
codons UAA and UGA or the glutamine codon CAG were
introduced using the Quick Change Site-Directed Mutagenesis
Kit (Stratagene). To carry out the mutagenesis procedure, an
4-Kb 5 fragment containing the Gag termination codon was
subcloned into the XhoI restriction site of pBSK (Stratagene). The
UAA mutation was introduced using the following primer pair:
5-CTCCTGACCCTAGATGACTTAAGGAGGTCAGGGT-
CAGGAGCC-3; 3-GAGGACTGGGATCTACTGATT-
CCTCCAGTCCCAGTCCTCGG-5. The UGA mutation was
introduced using the following primer pair; 5-CCTCCT-
GACCCTAGATGACTGAGGAGGTCAGGGTCAGGAG-
CC-3; 3-GGAGGACTGGGATCTACTGACTCCTCCAGT-
CCCAGTCCTCGG-5. The CAG mutation was introduced us-
ing the following primer pair: 5-CCCTCCTGACCCTAGAT-
GACCAGGGAGGTCAGGGTCAGGAG-3; 3-GGGAGGA-
CTGGGATCTACTGGTCCCTCCAGTCCCAGTCCTC-5.
Clones containing the correct mutations were identified by
sequencing and cloned into the pBAC4x-1 backbone con-
taining the 3 fragment of the gag-pol gene.
Production of recombinant baculoviruses
All recombinant baculoviruses were derived from Autog-
rapha californica nuclear polyhedrosis virus (AcNPV). The
baculoviruses were generated by cotransfecting Sf9 cells
with recombinant transfer vector (0.5 g) and linear
BacPAK6 viral DNA (1 L) (Clontech). Cell supernatants,
harvested after 5 days, were plaque assayed and plaques
were picked and grown for virus stocks as described by
King and Possee (1992). Recombinant baculoviruses were
confirmed by the immunodetection of Gag at 2 days pi and
high-titre stocks were generated.
Expression and preparation of MLV proteins
MLV proteins were expressed in insect cells by infecting
monolayers of 70% confluent Sf9 cells with recombinant
baculovirus according to the methods described by King
and Possee (1992). Infections were carried out at an m.o.i.
of 5. MLV proteins were transiently expressed in mamma-
lian 293T cells seeded at 70% confluence, using the profec-
tin calcium phosphate transfection system (Promega). The
cells were transfected with plasmid pHIT60 encoding the
MLV gag-pol genes (Soneoka et al., 1995). Sf9 and 293T
cells were harvested 48 h postinfection or transfection and
lysed in cell lysis buffer (1 PBS, 1% v/v NP-40) for 20
min at 4°C followed by clarification at 14K rpm for 10 min
at 4°C. Protein concentrations were determined using a
Bio-Rad protein assay kit. Cell supernatant was clarified (4
K rpm, 4°C, 5 followed by 10 K rpm, 4°C, 10) and
secreted protein was pelleted (14K rpm, 4°C, 30). The
resulting pellet was washed once in PBS and resuspended in
10 l of H2O.
SDS–PAGE and Western blotting
Protein samples were prepared in Laemmli sample buffer
(Laemmli, 1970) and separated by 12% SDS–PAGE. For
Western blots, proteins were transferred to PVDF mem-
brane (Immobolin-P, Millipore) and blocked for 1 h at room
temperature in PBS containing 0.1% Tween 20 (PBS-T) and
5% w/v milk powder. Incubation with anti-p30Gag antibody
(1:5000, Quality Biotech Inc.) was conducted for 1 h at
room temperature followed by washing several times with
PBS-T. Membranes were incubated a further hour with
peroxidase-conjugated rabbit anti-goat antibody (Sigma)
and bound antibodies were detected by chemiluminescence
(Roche). Relative band intensities of scanned images were
estimated using Phoretix software (Phoretic International).
Isolation and purification of virus-like particles
VLPs present in the supernatant were collected 48 h
postinfection or transfection by centrifugation at 24K rpm
for 1 h at 4°C, in a SW28 rotor (Beckman). The pellet was
resuspended in PBS and loaded onto a 20–60% w/v step
sucrose gradient and centrifuged at 30K rpm, 4°C for 1.5 h
in a SW41 rotor (Beckman). Fractions were collected from
the top and a 10-L aliquot of each fraction was analysed
by SDS–PAGE and Western blot.
Reverse transcriptase assay
Particles in the supernatants were concentrated by sedi-
mentation as described and reverse transcriptase (RT) ac-
tivity was assessed in triplicate using the Quant-T-RT kit
(Amersham Pharmacia), which utilizes the scintillation
proximity assay (SPA) principle to measure reverse tran-
scriptase activity by incorporation of [3H]TTP by reverse
494 C.S. Adamson et al. / Virology 314 (2003) 488–496
transcriptase into a DNA/RNA primer/template bound to
SPA beads. The kit was used according to the manufacturers
instructions except a modified assay buffer (50 mM Tris–
HCl, pH 8.0, 20mM DTT, 0.6mM MnCl2, 60 mM NaCl,
0.05% v/v NP-40) was used. Purified MLV reverse tran-
scriptase (Gibco BRL Life Technologies), which gave an
activity linearly to dose, was used as a positive control.
Electron microscopy
The procedure followed was that described by Jowett et
al. (1992). Briefly infected or transfected cells were dis-
lodged by gentle tapping and collected by low-speed cen-
trifugation at 1K rpm for 5 min at 21°C. The cells were
resuspended in 0.1 M sodium cacodylate buffer pH 7.4
containing 1% v/v gluteraldehyde (25% w/v EM grade).
Following fixation, the cells were embedded in Araldite,
sectioned, and poststained with uranyl acetate as described
by Hockley et al. (1988). Specimens were examined using a
Philips CM12 electron microscope operating at 80 kV.
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